VanEck Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
57.57 +0.31  +0.54% NASDAQ Sep 30, 16:59 Delayed 2m USD
View Full Chart
PPH Price Chart

PPH Key Stats

Expense Ratio 0.36%
Share Class Assets Under Management 231.94M
30-Day Average Daily Volume Upgrade
Net Asset Value 58.84
Discount or Premium to NAV 0.03%
Turnover Ratio 12.00

PPH Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV) Cat. Total Return (Price) % Rank in Cat. (Price)
1M -3.64% 0.85% 92 3.32% 97
3M -1.00% 6.86% 92 11.47% 91
6M 0.81% 12.05% 100 16.84% 93
1Y -4.41% 7.39% 82 8.28% 92
3Y 26.68% 12.54% 67 13.10% 85
5Y -- 19.76% -- 20.28% --
As of Sept. 28, 2016

PPH Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.92% 99.92% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.08% 0.08% 0.00
As of Sept. 29, 2016

PPH Region Exposure

Americas 69.42%
North America 69.42%
Latin America 0.00
Greater Europe 30.58%
United Kingdom 11.60%
Europe Developed 14.78%
Europe Emerging 0.00
Africa/Middle East 4.21%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Sept. 29, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Sept. 28, 2016

PPH Stock Market Capitalization

Giant 59.28%
Large 29.45%
Medium 10.50%
Small 0.77%
Micro 0.00
As of Sept. 28, 2016

PPH Stock Style Exposure

Large Cap Value 19.18%
Large Cap Blend 41.56%
Large Cap Growth 28.11%
Mid Cap Value 0.99%
Mid Cap Blend 6.32%
Mid Cap Growth 3.08%
Small Cap Value 0.00
Small Cap Blend 0.76%
Small Cap Growth 0.00
As of Sept. 29, 2016
View More Holdings

PPH Top 10 Holdings

Symbol Name % Weight Price % Chg
AZN AstraZeneca PLC ADR 5.16% 32.87 -0.54%
NVS Novartis AG ADR 5.11% 78.95 -0.38%
MRK Merck & Co Inc 5.10% 62.40 +0.79%
JNJ Johnson & Johnson 5.08% 118.12 +0.72%
GSK GlaxoSmithKline PLC ADR 5.07% 43.12 +0.51%
ABBV AbbVie Inc 5.01% 63.07 +0.40%
PFE Pfizer Inc 4.95% 33.86 +1.62%
SNY Sanofi SA ADR 4.95% 38.20 +0.98%
BMY Bristol-Myers Squibb Company 4.93% 53.95 +0.15%
LLY Eli Lilly and Co 4.73% 80.24 +0.63%
As of Sept. 29, 2016
Advertisement

One Page Reports

PPH Basic Info

Style
Equity Style Large Cap/Blend
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Market Vectors
Benchmark Index
MVIS US Listed Pharmaceutical 25 NR USD
100.0%

PPH Manager Info

Name Tenure
George Chao 4.70 yrs
Hao-Hung (Peter) Liao 4.70 yrs

PPH Net Fund Flows

1M 12.82M
3M 6.846M
6M -18.62M
YTD -67.84M
1Y -56.90M
3Y -28.90M
5Y --
10Y --
As of Aug. 31, 2016

PPH Risk Info

Beta 0.872
Max Drawdown (All) 25.51%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.666
30-Day Rolling Volatility 15.40%
Daily Value at Risk (VaR) 1% (All) 2.29%
Monthly Value at Risk (VaR) 1% (All) 8.72%

PPH Fundamentals

Dividend Yield TTM (9-30-16) 2.43%
Weighted Average PE Ratio 25.88
Weighted Average Price to Sales Ratio 1.267
Weighted Average Price to Book Ratio 3.294
Weighted Median ROE 20.53%
Weighted Median ROA 6.30%
Forecasted Dividend Yield 2.25%
Forecasted PE Ratio 19.58
Forecasted Price to Sales Ratio 1.130
Forecasted Price to Book Ratio 2.838
Number of Holdings 26
As of Sept. 29, 2016

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 8.63%
Forecasted Book Value Growth 8.38%
Forecasted Cash Flow Growth 14.33%
Forecasted Earnings Growth -2.18%
Forecasted Revenue Growth 13.07%
As of Sept. 29, 2016

PPH Comparables

Edit

PPH Attributes

Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2015
Last Prospectus Date 2/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

PPH Excel Add-In Codes

  • Name: =YCI("PPH","name")
  • Broad Asset Class: =YCI("PPH", "broad_asset_class")
  • Broad Category: =YCI("PPH", "broad_category_group")
  • Prospectus Objective: =YCI("PPH", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.